42
Views
13
CrossRef citations to date
0
Altmetric
Original Paper

CYP2D6 genotypes and depressive symptoms during late pregnancy and postpartum

, , , , &
Pages 61-64 | Accepted 17 Oct 2002, Published online: 12 Jul 2009

References

  • Bertilsson L, Dahl M-L. Polymorphic drug oxidation: Relevance to the treatment of psychiatric disorders. CNS Drugs 1996;5:200–23.
  • Niznik HB, Tyndale RF, Sallee FR, Gonzalez FJ, Hardwick JP, Inaba T, et al. The dopamine transporter and cytochrome P4501ID1 (Debrisoquine 4-hydroxylase) in brain: Resolution and identification of two distinct (3H) GBR-12935 binding proteins. Arch Biochem Biophysics 1990;276:424–32.
  • Tyndale RF, Sunahara R, Inaba T, Kalow W, Gonzalez FJ, Niznik HB. Neuronal cytochrome P4501ID1 (debrisoquine/sparteine type) potent inhibition of activity by (-)-cocaine snd nucleotide sequence identity to human hepatic P450 gene CYP2D6. Molec Pharmacol 1991;40:63–8.
  • Kalow W, Tyndale RF. Debrisoquine/Sparteine monooxygenase and other P-450s in brain. In: Kalow W, editor. Pharmacogenetics of drug metabolism. International Encyclopedia of Pharmacology and Therapeutics. London: Pergamon Press; 1992. p. 649–56.
  • Eichelbaum M, Mineshita S, Ohnhaus EE, Zekorn C. The influence of enzyme induction on polymorphic sparteine oxidation. Br J Clin Pharmac 1986;22:49–53.
  • Dahl M-L, Johansson I, Bertilsson L, Ingelman-Sundberg M, Sjöqvist F. Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis. J Pharmacol Exp Ther 1995;274:516–20.
  • Tamminga WJ, Wemer J, Oosterhuis B, de Zeeuw RA, de Leij LF, Jonkman JH. The prevalence of CYP2D6 and CYP2C19 geno-types in a population of healthy Dutch volunteers. Eur J Clin Pharmacol 2001;57: 717–22.
  • Griese EU, Zanger UM, Brudermanns U, Gaedigk A, Mikus G, Mörike K, et al. Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population. Pharmacogenetics 1998;8: 15–26.
  • Bertilsson L, Alm C, De Las Carreras C, Widen J, Edman G, Schalling D. Debrisoquine hydoxylation polymorphism and per-sonality. Lancet 1989;ii:555.
  • Llerena A, Edman G, Cobaleda J, Benitez J, Schalling D, Bertilsson L. Relationship between personality and debrisoquine hydroxylation capacity. Acta Psychiatr Scand 1993;87:23–8.
  • Weissman MM, Olfson M. Depression in women: Implications for health care research. Science 1995;269:799–801.
  • Llewellyn AM, Stowe ZN, Nemeroff CB. Depression during pregnancy and the puerperium. J Clin Psychiatry 1997;58(Suppl 15):26–32.
  • Josefsson A, Berg G, Nordin C, Sydsjö G. Prevalence of depressive symptoms in late pregnancy and postpartum. Acta Obstet Gynecol Scand 2001;80:251–5.
  • Cox J, Holden J, editor. Perinatal psychiatry: Use and misuse of the Edinburgh Postpartum Depression Scale. London: Gaskell; 1994.
  • Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves U. A population-based twin study of major depression in women. The impact of varying definitions of illness. Arch Gen Psychiatry 1992;49:257–66.
  • Kendler KS, Eaves LJ, Walters EE, Neale MC, Heath AC, Kessler RC. The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Arch Gen Psychiatry 1996;53:391–9.
  • Treloar SA, Martin NG, Bucholz KK, Madden PAF, Heath AC. Genetic influences on post-natal depressive symptoms: Findings from an Australian twin sample. Psychol Med 1999;29:645–54.
  • Högstedt S, Lindberg B, Rane A. Increased oral clearance of metoprolol in pregnancy. Eur J Clin Pharmacol 1983;24:217–20.
  • Wadelius M, Darj E, Frenne G, Rane A. Induction of CYP2D6 in pregnancy. Clin Pharmacol Ther 1997;62:400–7.
  • Högstedt S, Lindberg BS, Regardh CG, Mostrom U, Rane A. The Rhesus monkey as a model for studies of pregnancy-induced changes in metoprolol metabolism. Pharmacol Toxicol 1990;66:32–6.
  • Cox JL, Holden JM, Sagovsky R. Detection of postpartum depression; Development of the 10-item Edinburgh Postpartum Depression Scale. Br J Psychiatry 1987;150: 782–6.
  • Lund W, Gyllang C. Use of the Edinburgh Postpartum Depression Scale in some Swedish child health care centers. Scand J Caring Sci 1993;7:149–54.
  • Bagedahl-Strindlund M, Monsen Börjesson K. Postpartum de-pression: A hidden illness. Acta Psychiatr Scand 1998;98:272–5.
  • Wickberg B, Hwang CP. The Edinburgh Postpartum Depression Scale: Validation on a Swedish community sample. Acta Psychiatr Scand 1996;94:181–4.
  • Wolf CR, Moss JE, Miles JS, Gough AC, Spun NK. Detection of debrisoquine hydroxylation phenotypes. Lancet 1990;336:1452–3.
  • Smith CA, Gough AC, Leigh PN, Summers BA, Harding AE, Maraganore DM, et al. Debrisoquine hydroxylase gene poly-morphism and susceptibility to Parkinson's disease. Lancet 1992;339:1375–7.
  • Gough A, Miles JS, Spurr NK, Moss JE, Gaedigk A, Eichelbaum M, et al. Identification of the primary gene defect at the cytochrome P450 CYP2D locus. Nature 1990;347:773–6.
  • Steijns LSW, van der Weide J. Ultrarapid drug metabolism: PCR-based detection of CYP2D6 gene duplication. Clin Chem 1998;44:914–7.
  • Mattsson P, Bjelfman C, Lundberg PO, Rane A. Cytochrome P450 2D6 and glutathione S-transferase M1 genotypes and migraine. Eur J Clin Invest 2000;30:367–71.
  • Perrett CW, Clayton RN, Pistorello M, Boscaro M, Scanarini M, Bates AS, et al. GSTM1 and CYP2D6 genotype frequencies in patients with pitutary tumors: Effects on P53, ras and gsp. Carcinogenesis 1995;16:1643–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.